BioTissue Ocular

BioTissue Ocular We develop innovative Amniotic Membrane products for the management of ocular surface diseases.

BioTissue® is the leader in regenerative biologic therapies and ocular hygiene solutions, helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye.

BioTissue’s ocular portfolio leverages Cryopreserved Amniotic Membrane across a range of clinical applications to suppor...
06/02/2026

BioTissue’s ocular portfolio leverages Cryopreserved Amniotic Membrane across a range of clinical applications to support ocular surface healing, reduce dry eye signs and symptoms, and enhance patient outcomes.¹⁻²



1. John, T, Tighe, S, Sheha, H. et al. Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease. J Ophthalmol. 2017;2017:6404918. https://brnw.ch/21x32sB

2. McDonald, M, Janik, SB, Bowden, FW. et al. Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane. Clin Ophthalmol. 2023;Sep 12:17:2697- 2703. https://brnw.ch/21x32sC

We’re heading back to Kiawah Eye. Don’t miss the chance to hear from our President & CEO, Ted Davis, who will be present...
05/26/2026

We’re heading back to Kiawah Eye.

Don’t miss the chance to hear from our President & CEO, Ted Davis, who will be presenting on the Innovation Panel during the meeting.

Stop by to meet our team, and ask questions around Cryopreserved Amniotic Membrane for your patients. We’re here to share insights and help you find the right approach for ocular surface care.

05/21/2026

You asked the universe for a ringless CAM…

Data has shown CAM360 AmnioGraft™ promoted improvements in both signs and symptoms within 1-week in patients with mild to moderate DED.¹



Stevanovic, M, Ciarmiello, G, Eden, R, et al. Therapeutic Outcomes of Shelf-Stable, Cryopreserved Amniotic Membrane in Recalcitrant Keratopathy. Clin Ophthalmol. 2025;19:4545-4550. https://brnw.ch/21x2Hmm

Early intervention may help change the course of ocular surface disease. BioTissue’s Cryopreserved Amniotic Membrane (CA...
05/19/2026

Early intervention may help change the course of ocular surface disease.

BioTissue’s Cryopreserved Amniotic Membrane (CAM) exerts anti-inflammatory, anti-scarring, and anti-angiogenic actions to promote wound healing.¹

Explore CAM360 AmnioGraft, a CAM in-office therapy for managing mild–moderate cases.

Download the quick guide: https://brnw.ch/21x2DDQ

*Please refer to our Product Insert for storage information

1. Data on file.

PECAA + BioTissue = better together 🤝 We’re heading to San Diego next week and bringing our team with us. Look out for t...
05/14/2026

PECAA + BioTissue = better together 🤝

We’re heading to San Diego next week and bringing our team with us. Look out for these faces, we are here to help you make the most of your PECAA partnership.

Great connecting with Vision Source partners and bringing this collaboration to life. From real conversations to hands-o...
05/07/2026

Great connecting with Vision Source partners and bringing this collaboration to life. From real conversations to hands-on wet lab experience with Cryopreserved Amniotic Membrane, it was all about showing how CAM360 AmnioGraft™, Prokera® Slim, and Prokera® Clear, can fit into your practice.

Take full advantage of your Vision Source partnership. Connect with our team: https://biotissue.com/contact-us/

Great connecting with Vision Source partners and bringing this collaboration to life. From real conversations to hands-o...
05/07/2026

Great connecting with Vision Source partners and bringing this collaboration to life. From real conversations to hands-on wet lab experience with Cryopreserved Amniotic Membrane, it was all about showing how CAM360 AmnioGraft™, Prokera® Slim, and Prokera® Clear, can fit into your practice.

Take full advantage of your Vision Source partnership. Connect with our team: https://brnw.ch/21x2i3v

Great conversations at Intrepid Eye. Our VP of Marketing, Tiffany Matthews, joined the panel on influencing OD behavior,...
05/06/2026

Great conversations at Intrepid Eye.

Our VP of Marketing, Tiffany Matthews, joined the panel on influencing OD behavior, highlighting an important shift: interventional treatments can play a bigger role in how optometry approaches ocular surface disease.

We also had the opportunity to hear directly from an advisory board, with valuable insights that continue to shape how we support the optometric community.

Thank you to Intrepid Eye for bringing together such meaningful conversations.

Vision Source members, don’t forget to take advantage of your partnership with BioTissue! We’ll be at Vision Source Exch...
04/27/2026

Vision Source members, don’t forget to take advantage of your partnership with BioTissue!

We’ll be at Vision Source Exchange and would love to connect. Stop by to speak with our team and learn how our Cryopreserved Amniotic Membrane products (Prokera® and CAM360 AmnioGraft™) can support your practice and your patients.

Stop by our booth and take advantage of our promo!

04/22/2026

Cryopreserved Amniotic Membrane (CAM) supports ocular surface healing across the full spectrum of ocular surface disease severity.

From mild to severe ocular surface disease, CAM provides healing properties that can help reduce inflammation, promote epithelialization, and support restoration of the ocular surface.¹

Explore BioTissue’s CAM portfolio:
• CAM360 AmnioGraftTM
• Prokera®
• AmnioGraft®
• AmnioGuard®



1. Data on file.

Address

7300 Corporate Center Drive, Suite 700
Miami, FL
33126

Website

Alerts

Be the first to know and let us send you an email when BioTissue Ocular posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category